APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buspirone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Buspirone Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchBuspirone Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Buspirone Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Buspirone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buspirone Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Buspirone Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Buspirone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Buspirone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Buspirone market include Teva, Novartis, Mylan, Wockhardt, Watson Laboratories, Orion Corporation, Laboratoires Servier, Hikma and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Buspirone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Buspirone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Buspirone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Buspirone market size, projected growth trends, production technologies, key applications, and end-use industries.

Buspirone Segment by Company

Teva

Novartis

Mylan

Wockhardt

Watson Laboratories

Orion Corporation

Laboratoires Servier

Hikma

Dr. Reddy's Laboratories

Cadila Healthcare

Bristol Myers Squibb

Apotex

AMAG Pharmaceuticals

Buspirone Segment by Type

10mg

15mg

30mg

5mg

Buspirone Segment by Application

Hospital

Drug Store

Buspirone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Buspirone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Buspirone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Buspirone significant trends, drivers, influence factors in global and regions.

6. To analyze Buspirone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buspirone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buspirone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buspirone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Buspirone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Buspirone industry.

Chapter 3: Detailed analysis of Buspirone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Buspirone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Buspirone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Buspirone Industry Trends Table 2. Buspirone Industry Drivers Table 3. Buspirone Industry Opportunities and Challenges Table 4. Buspirone Industry Restraints Table 5. Global Buspirone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Buspirone Revenue Share by Company (2021-2026) Table 7. Global Buspirone Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Buspirone Sales Volume Share by Company (2021-2026) Table 9. Global Buspirone Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Buspirone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Buspirone Key Company Manufacturing Base & Headquarters Table 12. Global Buspirone Company, Product Type & Application Table 13. Global Buspirone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Buspirone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg Table 18. Significant Companies of 15mg Table 19. Significant Companies of 30mg Table 20. Significant Companies of 5mg Table 21. Global Buspirone Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Buspirone Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Buspirone Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Buspirone Sales Volume Share by Type (2021-2026) Table 25. Global Buspirone Sales Volume Share by Type (2027-2032) Table 26. Global Buspirone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Buspirone Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Buspirone Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Buspirone Sales Value Share by Type (2021-2026) Table 30. Global Buspirone Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Drug Store Table 33. Global Buspirone Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Buspirone Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Buspirone Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Buspirone Sales Volume Share by Application (2021-2026) Table 37. Global Buspirone Sales Volume Share by Application (2027-2032) Table 38. Global Buspirone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Buspirone Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Buspirone Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Buspirone Sales Value Share by Application (2021-2026) Table 42. Global Buspirone Sales Value Share by Application (2027-2032) Table 43. Global Buspirone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Buspirone Sales by Region (2021-2026) & (K Units) Table 45. Global Buspirone Sales Market Share by Region (2021-2026) Table 46. Global Buspirone Sales by Region (2027-2032) & (K Units) Table 47. Global Buspirone Sales Market Share by Region (2027-2032) Table 48. Global Buspirone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Buspirone Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Buspirone Sales Value Share by Region (2021-2026) Table 51. Global Buspirone Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Buspirone Sales Value Share by Region (2027-2032) Table 53. Global Buspirone Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Buspirone Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Buspirone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Buspirone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Buspirone Sales by Country (2021-2026) & (K Units) Table 58. Global Buspirone Sales Market Share by Country (2021-2026) Table 59. Global Buspirone Sales by Country (2027-2032) & (K Units) Table 60. Global Buspirone Sales Market Share by Country (2027-2032) Table 61. Global Buspirone Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Buspirone Sales Value Market Share by Country (2021-2026) Table 63. Global Buspirone Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Buspirone Sales Value Market Share by Country (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Teva Buspirone Product Portfolio Table 69. Teva Recent Development Table 70. Novartis Company Information Table 71. Novartis Business Overview Table 72. Novartis Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Novartis Buspirone Product Portfolio Table 74. Novartis Recent Development Table 75. Mylan Company Information Table 76. Mylan Business Overview Table 77. Mylan Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Mylan Buspirone Product Portfolio Table 79. Mylan Recent Development Table 80. Wockhardt Company Information Table 81. Wockhardt Business Overview Table 82. Wockhardt Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Wockhardt Buspirone Product Portfolio Table 84. Wockhardt Recent Development Table 85. Watson Laboratories Company Information Table 86. Watson Laboratories Business Overview Table 87. Watson Laboratories Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Watson Laboratories Buspirone Product Portfolio Table 89. Watson Laboratories Recent Development Table 90. Orion Corporation Company Information Table 91. Orion Corporation Business Overview Table 92. Orion Corporation Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Orion Corporation Buspirone Product Portfolio Table 94. Orion Corporation Recent Development Table 95. Laboratoires Servier Company Information Table 96. Laboratoires Servier Business Overview Table 97. Laboratoires Servier Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Laboratoires Servier Buspirone Product Portfolio Table 99. Laboratoires Servier Recent Development Table 100. Hikma Company Information Table 101. Hikma Business Overview Table 102. Hikma Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Hikma Buspirone Product Portfolio Table 104. Hikma Recent Development Table 105. Dr. Reddy's Laboratories Company Information Table 106. Dr. Reddy's Laboratories Business Overview Table 107. Dr. Reddy's Laboratories Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Dr. Reddy's Laboratories Buspirone Product Portfolio Table 109. Dr. Reddy's Laboratories Recent Development Table 110. Cadila Healthcare Company Information Table 111. Cadila Healthcare Business Overview Table 112. Cadila Healthcare Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Cadila Healthcare Buspirone Product Portfolio Table 114. Cadila Healthcare Recent Development Table 115. Bristol Myers Squibb Company Information Table 116. Bristol Myers Squibb Business Overview Table 117. Bristol Myers Squibb Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Bristol Myers Squibb Buspirone Product Portfolio Table 119. Bristol Myers Squibb Recent Development Table 120. Apotex Company Information Table 121. Apotex Business Overview Table 122. Apotex Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Apotex Buspirone Product Portfolio Table 124. Apotex Recent Development Table 125. AMAG Pharmaceuticals Company Information Table 126. AMAG Pharmaceuticals Business Overview Table 127. AMAG Pharmaceuticals Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. AMAG Pharmaceuticals Buspirone Product Portfolio Table 129. AMAG Pharmaceuticals Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Buspirone Distributors List Table 133. Buspirone Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Buspirone Product Image Figure 2. Global Buspirone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buspirone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Buspirone Sales (2021-2032) & (K Units) Figure 5. Global Buspirone Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Buspirone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg Image Figure 10. 15mg Image Figure 11. 30mg Image Figure 12. 5mg Image Figure 13. Global Buspirone Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Buspirone Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Buspirone Sales Volume Share by Type (2021-2032) Figure 16. Global Buspirone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Buspirone Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Buspirone Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Drug Store Image Figure 21. Global Buspirone Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Buspirone Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Buspirone Sales Volume Share by Application (2021-2032) Figure 24. Global Buspirone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Buspirone Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Buspirone Sales Value Share by Application (2021-2032) Figure 27. Global Buspirone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Buspirone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Buspirone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Buspirone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Buspirone Sales Value (2021-2032) & (US$ Million) Figure 32. North America Buspirone Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Buspirone Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Buspirone Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Buspirone Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Buspirone Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Buspirone Sales Value (2021-2032) & (US$ Million) Figure 38. South America Buspirone Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Buspirone Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Buspirone Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Buspirone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Buspirone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Buspirone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Buspirone Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Buspirone Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 15mg
  • 30mg
  • 5mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva
  • Novartis
  • Mylan
  • Wockhardt
  • Watson Laboratories
  • Orion Corporation
  • Laboratoires Servier
  • Hikma
  • Dr. Reddy's Laboratories
  • Cadila Healthcare
  • Bristol Myers Squibb
  • Apotex
  • AMAG Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Buspirone Sales Value (2021-2032)
  4. 1.2.2 Global Buspirone Sales Volume (2021-2032)
  5. 1.2.3 Global Buspirone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Buspirone Market Dynamics
  1. 2.1 Buspirone Industry Trends
  2. 2.2 Buspirone Industry Drivers
  3. 2.3 Buspirone Industry Opportunities and Challenges
  4. 2.4 Buspirone Industry Restraints
3 Buspirone Market by Company
  1. 3.1 Global Buspirone Company Revenue Ranking in 2025
  2. 3.2 Global Buspirone Revenue by Company (2021-2026)
  3. 3.3 Global Buspirone Sales Volume by Company (2021-2026)
  4. 3.4 Global Buspirone Average Price by Company (2021-2026)
  5. 3.5 Global Buspirone Company Ranking (2024-2026)
  6. 3.6 Global Buspirone Company Manufacturing Base and Headquarters
  7. 3.7 Global Buspirone Company Product Type and Application
  8. 3.8 Global Buspirone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Buspirone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Buspirone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Buspirone Market by Type
  1. 4.1 Buspirone Type Introduction
  2. 4.1.1 10mg
  3. 4.1.2 15mg
  4. 4.1.3 30mg
  5. 4.1.4 5mg
  6. 4.2 Global Buspirone Sales Volume by Type
  7. 4.2.1 Global Buspirone Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Buspirone Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Buspirone Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Buspirone Sales Value by Type
  11. 4.3.1 Global Buspirone Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Buspirone Sales Value by Type (2021-2032)
  13. 4.3.3 Global Buspirone Sales Value Share by Type (2021-2032)
5 Buspirone Market by Application
  1. 5.1 Buspirone Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Buspirone Sales Volume by Application
  5. 5.2.1 Global Buspirone Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Buspirone Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Buspirone Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Buspirone Sales Value by Application
  9. 5.3.1 Global Buspirone Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Buspirone Sales Value by Application (2021-2032)
  11. 5.3.3 Global Buspirone Sales Value Share by Application (2021-2032)
6 Buspirone Regional Sales and Value Analysis
  1. 6.1 Global Buspirone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Buspirone Sales by Region (2021-2032)
  3. 6.2.1 Global Buspirone Sales by Region: 2021-2026
  4. 6.2.2 Global Buspirone Sales by Region (2027-2032)
  5. 6.3 Global Buspirone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Buspirone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Buspirone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Buspirone Sales Value by Region (2027-2032)
  9. 6.5 Global Buspirone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Buspirone Sales Value (2021-2032)
  12. 6.6.2 North America Buspirone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Buspirone Sales Value (2021-2032)
  15. 6.7.2 Europe Buspirone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Buspirone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Buspirone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Buspirone Sales Value (2021-2032)
  21. 6.9.2 South America Buspirone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Buspirone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Buspirone Sales Value Share by Country, 2025 VS 2032
7 Buspirone Country-level Sales and Value Analysis
  1. 7.1 Global Buspirone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Buspirone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Buspirone Sales by Country (2021-2032)
  4. 7.3.1 Global Buspirone Sales by Country (2021-2026)
  5. 7.3.2 Global Buspirone Sales by Country (2027-2032)
  6. 7.4 Global Buspirone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Buspirone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Buspirone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Buspirone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Buspirone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Buspirone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Buspirone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Buspirone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Buspirone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Buspirone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Buspirone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Buspirone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Buspirone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Buspirone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Buspirone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Buspirone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Buspirone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Buspirone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Buspirone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Buspirone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Buspirone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Buspirone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Buspirone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Buspirone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Buspirone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Buspirone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Buspirone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Buspirone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Buspirone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Buspirone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Buspirone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Buspirone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Buspirone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Buspirone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Buspirone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Buspirone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Buspirone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Buspirone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Buspirone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Buspirone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Buspirone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Buspirone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Buspirone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Buspirone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Buspirone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Buspirone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Buspirone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Buspirone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Buspirone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Buspirone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Buspirone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Buspirone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Buspirone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Buspirone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Buspirone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Buspirone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Buspirone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Buspirone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Buspirone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Buspirone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Buspirone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Buspirone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Buspirone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Buspirone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Buspirone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Buspirone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Buspirone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Buspirone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Buspirone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Buspirone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Buspirone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Buspirone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Buspirone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Buspirone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Buspirone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Buspirone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Buspirone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Buspirone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Buspirone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Buspirone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Buspirone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Buspirone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Buspirone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Buspirone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Buspirone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Buspirone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Buspirone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Buspirone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Buspirone Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Buspirone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Buspirone Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Buspirone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Buspirone Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Wockhardt
  20. 8.4.1 Wockhardt Company Information
  21. 8.4.2 Wockhardt Business Overview
  22. 8.4.3 Wockhardt Buspirone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Wockhardt Buspirone Product Portfolio
  24. 8.4.5 Wockhardt Recent Developments
  25. 8.5 Watson Laboratories
  26. 8.5.1 Watson Laboratories Company Information
  27. 8.5.2 Watson Laboratories Business Overview
  28. 8.5.3 Watson Laboratories Buspirone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Watson Laboratories Buspirone Product Portfolio
  30. 8.5.5 Watson Laboratories Recent Developments
  31. 8.6 Orion Corporation
  32. 8.6.1 Orion Corporation Company Information
  33. 8.6.2 Orion Corporation Business Overview
  34. 8.6.3 Orion Corporation Buspirone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Orion Corporation Buspirone Product Portfolio
  36. 8.6.5 Orion Corporation Recent Developments
  37. 8.7 Laboratoires Servier
  38. 8.7.1 Laboratoires Servier Company Information
  39. 8.7.2 Laboratoires Servier Business Overview
  40. 8.7.3 Laboratoires Servier Buspirone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Laboratoires Servier Buspirone Product Portfolio
  42. 8.7.5 Laboratoires Servier Recent Developments
  43. 8.8 Hikma
  44. 8.8.1 Hikma Company Information
  45. 8.8.2 Hikma Business Overview
  46. 8.8.3 Hikma Buspirone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hikma Buspirone Product Portfolio
  48. 8.8.5 Hikma Recent Developments
  49. 8.9 Dr. Reddy's Laboratories
  50. 8.9.1 Dr. Reddy's Laboratories Company Information
  51. 8.9.2 Dr. Reddy's Laboratories Business Overview
  52. 8.9.3 Dr. Reddy's Laboratories Buspirone Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Reddy's Laboratories Buspirone Product Portfolio
  54. 8.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 8.10 Cadila Healthcare
  56. 8.10.1 Cadila Healthcare Company Information
  57. 8.10.2 Cadila Healthcare Business Overview
  58. 8.10.3 Cadila Healthcare Buspirone Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cadila Healthcare Buspirone Product Portfolio
  60. 8.10.5 Cadila Healthcare Recent Developments
  61. 8.11 Bristol Myers Squibb
  62. 8.11.1 Bristol Myers Squibb Company Information
  63. 8.11.2 Bristol Myers Squibb Business Overview
  64. 8.11.3 Bristol Myers Squibb Buspirone Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Bristol Myers Squibb Buspirone Product Portfolio
  66. 8.11.5 Bristol Myers Squibb Recent Developments
  67. 8.12 Apotex
  68. 8.12.1 Apotex Company Information
  69. 8.12.2 Apotex Business Overview
  70. 8.12.3 Apotex Buspirone Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Apotex Buspirone Product Portfolio
  72. 8.12.5 Apotex Recent Developments
  73. 8.13 AMAG Pharmaceuticals
  74. 8.13.1 AMAG Pharmaceuticals Company Information
  75. 8.13.2 AMAG Pharmaceuticals Business Overview
  76. 8.13.3 AMAG Pharmaceuticals Buspirone Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 AMAG Pharmaceuticals Buspirone Product Portfolio
  78. 8.13.5 AMAG Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Buspirone Value Chain Analysis
  2. 9.1.1 Buspirone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Buspirone Sales Mode & Process
  6. 9.2 Buspirone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Buspirone Distributors
  9. 9.2.3 Buspirone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst